Description
Ryzumvi (phentolamine ophthalmic solution) 0.75% — a topical alpha adrenergic blocker indicated for the treatment of pharmacologically-induced mydriasis produced by adrenergic agonists or parasympatholytic agents. Ocuphire Pharma, carton of 30 single-patient-use vials.
If you have any questions related to compliance, licensing, regulatory data or quality assurance, please contact our team at compliance@dryeyerescue.com